13/09/2022 / News
WhiteLab Genomics lève 10 millions d’euros pour sa plateforme de simulation des thérapies géniques
WhiteLab Genomics a développé une plateforme de simulation dédiée aux thérapies géniques. Elle permettrait d'accélérer la procédure pour les entreprises...
En savoir plus
13/09/2022 / News
TechCrunch: How WhiteLab Genomics is using AI to aid gene and cell therapy development
French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and...
En savoir plus
05/09/2022
17 Top YC Companies Applying AI for a Better Future
Y Combinator is probably the world´s most well-known startup accelerator. Identifying the top startups from thousands of Y Combinator companies...
En savoir plus
16/06/2022 / News
L’Institut Curie et Microsoft s’associent et lancent le Biotech Scaler Program
Objectif : accompagner les biotech et les medtech dans leur croissance. Quatre startups font d’ores et déjà partie du programme...
En savoir plus
16/05/2022
Inauguration of Future4Care, a digital health startup accelerator
Whitelab Genomics, along with other startups, participated to the inauguration of Future4Care, a digital health startup acceleator founded by Sanofi,...
En savoir plus
30/03/2022 / News
Selected AI startups from YC’s Winter ’22 batch
Dozens of startups in Y Combinator’s Winter 2022 cohort do something that could be described as artificial intelligence. Though the...
En savoir plus
07/03/2022
Meet the startups in Y Combinator’s latest Intake
Y Combinator, the famed American startup accelerator, is continuing to bring in a substantial number of European startups. 17%, or...
En savoir plus
22/09/2021 / News
WhiteLab Genomics nominated to the Galien Medstartup Prize 2021!
We are proud to announce the nomination of WhiteLab Genomics for the Prix Galien Medstartup. About the Galien Foundation: The...
En savoir plus
02/09/2021 / News
WhiteLab Genomics names Dr. Nicole Paulk, Mr. Jean-Pascal Tranie and Dr. Magali Richard to its Scientific and Strategic Advisory Boards
Scientific and business leaders will reinforce our expertise as we develop data science and machine learning solutions for genomic medicine....
En savoir plus